IPI/NIVO for mCRC with Dr. Sharlene Gill

In this episode, Dr. Arndt Vogel takes us through targeted therapy in Biliary Tract Cancers. As we now have access to Pemigatinib (PART 1) to target FGFR2 fusions and Ivosidenib (PART 2) for IDH1 mutated cholangiocarcinoma, I thought it important to discuss how to incorporate the ...  Show more

In this episode, Dr. Arndt Vogel takes us through targeted therapy in Biliary Tract Cancers. As we now have access to Pemigatinib to target FGFR2 fusions and Ivosidenib for IDH1 mutated cholangiocarcinoma, I thought it important to discuss how to incorporate these into practice. 

In the next podcast episode, we will continue our talk on hemophilia. Specifically the treatment of hemophilia. We'll discuss the different types of therapy available, from traditional factor replacement to emerging gene-techniques. Join Dr. Niket Sonpal as he helps us manage hem ...  Show more

In this episode, we delve into the groundbreaking study "Influence of therapeutic plasma exchange treatment on short-term mortality of critically ill adult patients with sepsis-induced organ dysfunction." We explore how Therapeutic Plasma Exchange (TPE) could revolutionize the tr ...  Show more

In this 268th episode I welcome Drs. Carullo, Kostibas, Isaac, Banks and Segna to the show. They are our peds, cardiac, OB, critical care and regional fellowship directors and we discuss the state of fellowships in anesthesiology.Our Sponsors:* Check out BetterHelp: https://bette ...  Show more

Hypercholesterolemia is common condition with serious consequences. It is important that we assess, diagnose and manage it appropriately. To find out more about this problem and what we can do about it, please do listen to this BMJ Best Practice podcast interview with Thorsten Le ...  Show more